Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Bevacizumab may stop the growth of colorectal cancer by stopping
blood flow to the tumor.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus
bevacizumab in treating patients who have advanced colorectal cancer.